Description
This study will evaluate the effectiveness and safety of repeat administrations of NurOwn injections as compared to Placebo given three times two months apart to participants with ALS. The study will consist of a pre-treatment period of up to 5 months, treatment period for 4 months and a follow up period of 3 months.
Overview
The objective of this study is to find out the safety of a repeated use of the drug called NurOwn. We will whether it may decrease the rate of decline of the disease without causing too many side effects. To do this, study doctors will remove some of your bone marrow cells, treat them in a laboratory, and put them back into the fluid that surrounds the spinal cord. This study and cell treatment only involve cells from your body.
What we're hoping for
The purpose of the study is to evaluate the safety and effectiveness of the stem cell treatment as a treatment for ALS
Additional Information
ClinicalTrials.gov Identifier: NCT03280056